Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Motor neuron disease of paraneoplastic origin: a rare but treatable condition.
Mélé N, Berzero G, Maisonobe T, Salachas F, Nicolas G, Weiss N, Beaudonnet G, Ducray F, Psimaras D, Lenglet T. Mélé N, et al. Among authors: beaudonnet g. J Neurol. 2018 Jul;265(7):1590-1599. doi: 10.1007/s00415-018-8881-0. Epub 2018 May 3. J Neurol. 2018. PMID: 29725842 Review.
Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial.
Adams D, Tournev IL, Taylor MS, Coelho T, Planté-Bordeneuve V, Berk JL, González-Duarte A, Gillmore JD, Low SC, Sekijima Y, Obici L, Chen C, Badri P, Arum SM, Vest J, Polydefkis M; HELIOS-A Collaborators. Adams D, et al. Amyloid. 2023 Mar;30(1):1-9. doi: 10.1080/13506129.2022.2091985. Epub 2022 Jul 23. Amyloid. 2023. PMID: 35875890 Clinical Trial.
Motor unit number index as an individual biomarker: Reference limits of intra-individual variability over time in healthy subjects.
Delmont E, Wang F, Lefaucheur JP, Puma A, Breniere C, Beaudonnet G, Cintas P, Collin R, Fortanier E, Grapperon AM, Jomir L, Kribich H, Kouton L, Kuntzer T, Lenglet T, Magot A, Nordine T, Ochsner F, Bolloy G, Pereon Y, Salort-Campana E, Tard C, Vicino A, Verschueren A, Attarian S. Delmont E, et al. Among authors: beaudonnet g. Clin Neurophysiol. 2020 Sep;131(9):2209-2215. doi: 10.1016/j.clinph.2020.06.019. Epub 2020 Jul 9. Clin Neurophysiol. 2020. PMID: 32707479 Free article.
[Motor and/or sensory deficit of the limbs].
Not A, Beaudonnet G, Denier C. Not A, et al. Among authors: beaudonnet g. Rev Prat. 2017 Dec;67(10):e479-e488. Rev Prat. 2017. PMID: 30512623 French. No abstract available.
Impact of Coronavirus Disease 2019 in a French Cohort of Myasthenia Gravis.
Solé G, Mathis S, Friedman D, Salort-Campana E, Tard C, Bouhour F, Magot A, Annane D, Clair B, Le Masson G, Soulages A, Duval F, Carla L, Violleau MH, Saulnier T, Segovia-Kueny S, Kern L, Antoine JC, Beaudonnet G, Audic F, Kremer L, Chanson JB, Nadaj-Pakleza A, Stojkovic T, Cintas P, Spinazzi M, Foubert-Samier A, Attarian S. Solé G, et al. Among authors: beaudonnet g. Neurology. 2021 Apr 20;96(16):e2109-e2120. doi: 10.1212/WNL.0000000000011669. Epub 2021 Feb 10. Neurology. 2021. PMID: 33568541
Detailed clinical, physiological and pathological phenotyping can impact access to disease-modifying treatments in ATTR carriers.
Beauvais D, Labeyrie C, Cauquil C, Francou B, Eliahou L, Not A, Echaniz-Laguna A, Adam C, Slama MS, Benmalek A, Leonardi L, Rouzet F, Adams D, Algalarrondo V, Beaudonnet G. Beauvais D, et al. Among authors: beaudonnet g. J Neurol Neurosurg Psychiatry. 2024 May 14;95(6):489-499. doi: 10.1136/jnnp-2023-332180. J Neurol Neurosurg Psychiatry. 2024. PMID: 37875336 Free PMC article.
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study.
Adams D, Polydefkis M, González-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada López IA, Dispenzieri A, Quan D, Conceição IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, Planté-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH 3rd, Ueda M, Aldinc E, Wang JJ, White MT, Vest J, Berber E, Sweetser MT, Coelho T; patisiran Global OLE study group. Adams D, et al. Lancet Neurol. 2021 Jan;20(1):49-59. doi: 10.1016/S1474-4422(20)30368-9. Epub 2020 Nov 16. Lancet Neurol. 2021. PMID: 33212063 Clinical Trial.
Expression of Yo Antigen in a Prostatic Adenocarcinoma.
Rosine N, Chrétien P, Adam C, Beaudonnet G, Not A, Drai J, Vahedi K, Cauquil C, Theaudin M. Rosine N, et al. Among authors: beaudonnet g. Can J Neurol Sci. 2017 Mar;44(2):221-223. doi: 10.1017/cjn.2016.400. Can J Neurol Sci. 2017. PMID: 28231864 No abstract available.
21 results